Insys Therapeutics Inc (INSY) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Insys Therapeutics Inc develops and commercializes drugs delivery systems targeting the ...

For INSYS Therapeutics Inc’s (NASDAQ:INSY) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important ...

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most ...

The chart below shows where INSY has traded over the past year, with the 50-day and 200-day moving averages included. Special Offer: Join the income investing conversation on ValueForum.com with a ...

View post: Another popular beer brand closes its brewery forever ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Insys Therapeutics Inc (NASD: INSY), where a total volume of 3,885 contracts has ...

INSYS Therapeutics, Inc. INSY has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because INSY is now in overbought territory with an RSI value ...

Is Insys Therapeutics Inc (NASDAQ:INSY) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars ...

Insys Therapeutics (INSY) closed the most recent trading day at $4.81, moving +1.69% from the previous trading session. This change outpaced the S&P 500's 1.09% gain on the day. Elsewhere, the Dow ...